Substantial LVSI- can it guide optimal adjuvant treatment ?DrKamrava Matthew Harkenrider, MD Ann Klopp Scott Glaser #gynsm sciencedirect.com/science/articl…

I look forward to opening/offering this trial. Pretty easy logistics and a pure #RadOnc question. Also a rare and important ask: "are more fractions better?"

New #RedJournal article from @nrgonc, Long-term results of bladder preservation with twice-daily radiation plus 5-Flourouracil/Cisplatin or daily radiation plus gemcitabine for MIBC. #radonc tinyurl.com/redcoen

Neil Newman, MD, a radiation oncologist UT Health San Antonio MD Anderson, is part of a national study using low-dose radiation to treat osteoarthritis. Unlike cancer treatment, this therapy uses lower doses to target pain directly at the joint. Neil Newman Learn more: bit.ly/47h55eD

Single fraction RT (8Gy) significantly improves hepatic pain compared with best supportive care and can be considered standard palliative treatment. No increase in toxicity. Laura Dawson CCTG thelancet.com/journals/lanon…

Interesting read for all oncologist and specifically rad Onc ASTRO ARRO

Very proud to be the first cancer researcher to receive this national award. Clearly exercise oncology is mainstream!

brachyjournal.com/article/S1538-… Ria Mulherkar, MD Nikhil G. Thaker, MD DrKamrava Chirag Shah Sushil American Brachy ..."Role of simulation based training to improve brachytherapy competency among RO residents". An important conversation to have, also important for #medphys

Pleased to bring gallium-68 PET imaging to guide precision #radiation for patients with #meningioma, a type of benign brain tumour University Health Network Radiation Medicine Program uhn.ca/corporate/news…

Not often you get home from #WCLC24 and go through one of the talks with your children But have done just that with this outstanding presentation from Pamela Ling about vaping, cannabis and risk of lung cancer (whole PL05 session from Monday was superb) #LCSM

Barstool Pizza Review - A Slice of New York (Murrysville, PA)

Happy to announce that the PEACE 6 OligoPRESTO trial testing the role of metastasis directed therapy in hormone sensitive #ProstateCancer has completed accrual ahead of schedule. 550 patients randomized. Waiting now for data to mature.

In this JAMA Oncology Viewpoint, William A Hall, MD & I discuss a big challenge for radiation trials: patient accrual. We explain several reasons why RT trials have difficulty enrolling & propose potential solutions. Please take a read & share thoughts! jamanetwork.com/journals/jamao…

SBRT vs surgery QOL. Results similar to conventional RT vs surgery . Objective data for to help with counseling pts #pcsm Rahul Tendulkar, MD Amar Kishan Andrew Keller Hima Bindu Musunuru

Weekly is non inferior and also less toxic #hnsm

⚙️⚙️⚙️TOPGEAR presented today at #ESMO24: Preop chemoRT increased pCR but did not improve PFS or OS, compared to periop chemo for gastric cancer. Huge congrats to Trevor Leung and colleagues for this important trial! ⬇️1/6

Sweet Caroline… LET’S GO PITT 🎶

The inventor of liraglutide (one of the earlier GLP-1 drugs, like Ozempic) wrote a great history of its development. Many metascience gems on how mouse studies can both guide & mislead, the very long timelines in drug development, etc. [notes below]

Key slide from the ADRIATIC presentation at #ESMO24 3-yr OS rates: ▶️ BD RT: 65.8% (durva) vs 57.4% (placebo) ▶️ OD RT: 53.1% (durva) vs 43.3% (placebo) ➡️ survival superior with BD RT 📝 CONVERT trial and ESMO - Eur. Oncology guidelines support adopting BD RT in routine practice

Systematic review and recommendations for re-irradiation for intraprostatic radiorecurrent prostate cancer after definitive radiation therapy. pubmed.ncbi.nlm.nih.gov/39264453/